Dana Investment Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.65M Buy
1,944,607
+459,510
+31% +$1.43M 0.17% 147
2026
Q1
$3.39M Sell
1,485,097
-3,424
-0.2% -$7.88K 0.1% 232
2025
Q4
$4.17M Buy
1,488,521
+222,961
+18% +$797K 0.12% 192
2025
Q3
$6.07M Buy
1,265,560
+241,023
+24% +$1.53M 0.18% 140
2025
Q2
$9.32M Buy
1,024,537
+68,334
+7% +$504K 0.31% 71
2025
Q1
$8.63M Buy
956,203
+421,783
+79% +$4.45M 0.31% 72
2024
Q4
$6.98M Sell
534,420
-30,761
-5% -$410K 0.23% 112
2024
Q3
$8.87M Sell
565,181
-43,859
-7% -$664K 0.29% 86
2024
Q2
$8.22M Buy
609,040
+160,682
+36% +$3.29M 0.28% 97
2024
Q1
$12.4M Buy
+448,358
New +$9.96M 0.41% 64

Other funds holding ACH

Dana Investment Advisors's ACH Position: Q2 2026 in Review

Dana Investment Advisors increased its Accendra Health (ACH) stake by 31% in Q2 2026, buying an estimated $1.43M and bringing the position to 1,944,607 shares worth $6.65M. The position accounts for 0.17% of the portfolio, ranked #147.

Dana Investment Advisors first reported a position in ACH in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.4M in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Dana Investment Advisors held 1,944,607 shares of Accendra Health worth $6.65M as of Q2 2026.
  • Dana Investment Advisors bought 459,510 Accendra Health shares in Q2 2026, an estimated $1.43M.
  • Accendra Health made up 0.17% of Dana Investment Advisors's portfolio in Q2 2026, its #147 holding.
  • Dana Investment Advisors first reported a position in Accendra Health in Q1 2024 and has held it in 10 quarters since.
  • Dana Investment Advisors's Accendra Health position peaked at $12.4M in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.